收藏切换
The clinical study on Jiehe pills combined with 2HRZE/4HR regimen in the treatment of tuberculosis based on real world
收藏切换
Shouyong TAN1, Hua YAO2, Chunxiang LI3, Xiuhong XI4, Xilin ZHANG5, Taisheng MA6
World Clinical Drug | 2025, 46(8) : 785 - 790
Less
收藏切换
World Clinical Drug | 2025, 46(8): 785-790
The clinical study on Jiehe pills combined with 2HRZE/4HR regimen in the treatment of tuberculosis based on real world
Full
Shouyong TAN1, Hua YAO2, Chunxiang LI3, Xiuhong XI4, Xilin ZHANG5, Taisheng MA6
Affiliations
  • 1.The Guangzhou Tuberculosis Control Institute, State Key Laboratory of Respiratory Diseases, Guangzhou 510095, Guangdong Province,China
  • 2.Gansu Tianshui Qihuang Pharmaceutical Co., Ltd, Tianshui 100061, Gansu Province, China
  • 3.Department of Infectious Diseases,Changsha Central Hospital, Changsha 410008, Hunan Province, China
  • 4.Department of Tuberculosis, Shanghai Public Health Clinical Center, Shanghai 201508, China
  • 5.Department of Tuberculosis, Foshan Fourth People's Hospital, Foshan 528000, Guangdong Province,China
  • 6.Guangzhou haibote Medical Technology Co., Ltd, Guangzhou 510000, Guangdong Province, China
Published: 2025-08-10 doi: 10.13683/j.wph.2025.08.008
Outline
收藏切换
Objective

To explore the potential advantages of Jiehe pills combined with the standard anti-tuberculosis(TB) regimen(2HRZE/4HR) in improving clinical symptoms of newly diagnosed sputum-positive pulmonary TB patients in real-world settings, and to evaluate its safety.

Methods

A prospective observational study was conducted. A total of 480 newly diagnosed sputum-positive pulmonary TB patients from 5 hospitals between March 28, 2018, and April 28, 2021 were enrolled. Among them, 252 patients in the control group received the 2HRZE/4HR regimen alone, while 228 patients in the experimental group received Jiehe pills in addition to the control group. The sputum culture conversion rate, clinical symptom scores, quality of life scale scores, and incidence of adverse drug reactions were compared between the two groups after 6 months of treatment.

Results

After 6 months of treatment, the sputum culture conversion rate in the experimental group was slightly higher than the control group, but there was no statistical difference In terms of clinical symptoms, the total graded and quantified clinical symptom scores in the experimental group was significantly higher than the control group(difference in scores: experimental group vs. control group=1.087). Additionally, the disappearance rate of chest pain symptoms in the experimental group was significantly higher than that in the control group(80.65%vs. 47.37%, P=0.014).

Conclusions

The combination of Jiehe pills with the 2HRZE/4HR regimen did not significantly improve sputum culture conversion rates, but it effectively alleviated clinical symptoms—particularly chest pain.Moreover, it was safe and provided a new treatment option for newly diagnosed sputum-positive pulmonary TB patients,which could improve the quality of life of patients and hold significant clinical value.

Jiehe pill  /  2HRZE/4HR  /  tuberculosis  /  real-world study
谭守勇, 姚华, 李春香, 席秀红, 张锡林, 马泰生. 基于真实世界的结核丸联合2HRZE/4HR方案治疗初治菌阳肺结核的临床研究. 世界临床药物, 2025 , 46 (8) : 785 -790 . DOI: 10.13683/j.wph.2025.08.008
Shouyong TAN, Hua YAO, Chunxiang LI, Xiuhong XI, Xilin ZHANG, Taisheng MA. The clinical study on Jiehe pills combined with 2HRZE/4HR regimen in the treatment of tuberculosis based on real world[J]. World Clinical Drug, 2025 , 46 (8) : 785 -790 . DOI: 10.13683/j.wph.2025.08.008
Year 2025 volume 46 Issue 8
48
9
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.08.008
  • Receive Date:2025-02-21
  • Online Date:2026-11-09
  • Published:2025-08-10
Article Data
Affiliations
History
  • Received:2025-02-21
Affiliations
    1.The Guangzhou Tuberculosis Control Institute, State Key Laboratory of Respiratory Diseases, Guangzhou 510095, Guangdong Province,China
    2.Gansu Tianshui Qihuang Pharmaceutical Co., Ltd, Tianshui 100061, Gansu Province, China
    3.Department of Infectious Diseases,Changsha Central Hospital, Changsha 410008, Hunan Province, China
    4.Department of Tuberculosis, Shanghai Public Health Clinical Center, Shanghai 201508, China
    5.Department of Tuberculosis, Foshan Fourth People's Hospital, Foshan 528000, Guangdong Province,China
    6.Guangzhou haibote Medical Technology Co., Ltd, Guangzhou 510000, Guangdong Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.08.008
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT